Skip to main content

Allergen Immunotherapy

Section edited by Gianenrico Senna 

  1. Non-specific lipid-transfer protein (nsLTP) is a pan-allergen in the plant world, and a cause of significant concern as food allergen in the Mediterranean area, due to its general heat- and acid-resistance and...

    Authors: Carlo Maria Rossi, Marco Vincenzo Lenti, Stefania Merli, Amelia Licari, Gian Luigi Marseglia and Antonio Di Sabatino
    Citation: Clinical and Molecular Allergy 2023 21:3
  2. The concept of personalized medicine as a diagnostic and therapeutic approach tailored to the medical needs of each patient is currently revolutionizing all fields of medicine and in particular allergology. Al...

    Authors: Cristoforo Incorvaia, Erminia Ridolo, Diego Bagnasco, Silvia Scurati and Giorgio Walter Canonica
    Citation: Clinical and Molecular Allergy 2021 19:10
  3. House-dust mites (HDM) allergy is the prevailing condition in subjects allergic to inhalants. Clinical studies with HDM extracts—either subcutaneous (SCIT) or sublingual (SLIT) have long been characterized by ...

    Authors: Gianfranco Vitiello, Lucia Maltagliati and Oliviero Rossi
    Citation: Clinical and Molecular Allergy 2020 18:10
  4. Sublingual immunotherapy (SLIT) is effective, tolerable, and convenient for many allergic patients. Still, real-world evidence is scarce and the aim of this study is to assess the patient reported outcome of t...

    Authors: Christer Janson, Fredrik Sundbom, Peter Arvidsson and Mary Kämpe
    Citation: Clinical and Molecular Allergy 2018 16:14
  5. Allergen immunotherapy (AIT) is the only disease-modifying treatment approved for allergic rhinitis and allergic asthma and represents a suitable therapeutic option, especially in childhood, to modify the prog...

    Authors: Matteo Ferrando, Francesca Racca, Lorena Nascimento Girardi Madeira, Enrico Heffler, Giovanni Passalacqua, Francesca Puggioni, Niccolò Stomeo and Giorgio Walter Canonica
    Citation: Clinical and Molecular Allergy 2018 16:6
  6. Asthma, allergic rhinitis (AR) and atopic dermatitis are very common in young people, but in the latest decades it was increasingly recognized that also individuals of higher ages, including the population ove...

    Authors: Erminia Ridolo, Anti Rogkakou, Maria Teresa Ventura, Irene Martignago, Cristoforo Incorvaia, Gabriele Di Lorenzo and Giovanni Passalacqua
    Citation: Clinical and Molecular Allergy 2017 15:17
  7. Sublingual immunotherapy (SLIT) is a feasible option to classical subcutaneous immunotherapy to treat respiratory allergy and is increasingly prescribed in Europe. However, the lack of reimbursement may limit ...

    Authors: Ilaria Massaro, Oliviero Rossi, Cristoforo Incorvaia and Carlo Lombardi
    Citation: Clinical and Molecular Allergy 2017 15:15
  8. Allergen-specific immunotherapy (AIT) is the only treatment able to change the natural course of allergic diseases. We aimed at investigating the clinical efficacy of SLITOR (Serbian registered vaccine for sub...

    Authors: I. Djuric-Filipovic, Marco Caminati, D. Filipovic, C. Salvottini and Z. Zivkovic
    Citation: Clinical and Molecular Allergy 2017 15:7
  9. Allergic rhinitis has a very high burden regarding both direct and indirect costs. This makes essential in the management of AR to reduce the clinical severity of the disease and thus to lessen its costs. This...

    Authors: Carlo Lombardi, Valerie Melli, Cristoforo Incorvaia and Erminia Ridolo
    Citation: Clinical and Molecular Allergy 2017 15:5
  10. Airborne allergens can induce an immunological chronic disease characterized by airway hyper responsiveness and inflammation, mediated by exaggerated Th2 immune response. Allergen-specific immunotherapy (AIT) ...

    Authors: Claudia Petrarca, Emanuela Clemente, Valentina Amato, Alessia Gatta, Sara Cortese, Alessia Lamolinara, Cosmo Rossi, Stefania Zanotta, Gianni Mistrello, Roberto Paganelli and Mario Di Gioacchino
    Citation: Clinical and Molecular Allergy 2016 14:7
  11. Allergic respiratory diseases are constantly increasing in prevalence. Allergen Immunotherapy (AIT) represent a valuable therapeutic tool as symptomatic and preventative approach, expecially in children. In It...

    Authors: Massimo Landi, Paolo Meglio, Ermanno Praitano, Carlo Lombardi, Giovanni Passalacqua and Giorgio Walter Canonica
    Citation: Clinical and Molecular Allergy 2015 13:15

Annual Journal Metrics

  • 2022 Citation Impact
    0.927 - SNIP (Source Normalized Impact per Paper)
    0.583 - SJR (SCImago Journal Rank)

    2023 Speed
    191 days submission to accept (Median)

    2023 Usage 
    108 Altmetric mentions